Clinical trial
A Multicenter, Open-Label Study to Evaluate ARC-520 Administered Alone and in Combination With Other Therapeutics in Patients With Chronic Hepatitis B Virus (HBV) Infection (MONARCH)
NCT02577029 is registered in ClinicalTrials.gov with Arrowhead Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Open-Label Study to Evaluate ARC-520 Administered Alone and in Combination With Other Therapeutics in Patients With Chronic Hepatitis B Virus (HBV) Infection (MONARCH)
- Lead sponsor
- Arrowhead Pharmaceuticals
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- December 31, 2015
- Completion date
- December 31, 2016
- Enrollment
- 79 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.